Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer–Specific Mortality Stratified by the Extent of Competing Mortality
- 23 August 2016
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 96 (4) , 778-784
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJAMA, 2015
- Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate CancerAnnals of Internal Medicine, 2013
- Impact of Age and Comorbidities on Long-term Survival of Patients with High-risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Competing-risks AnalysisEuropean Urology, 2013
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate CancerNew England Journal of Medicine, 2011
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trialThe Lancet Oncology, 2011
- Impact of Comorbidity on Survival Among Men With Localized Prostate CancerJournal of Clinical Oncology, 2011
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- Duration of Androgen Suppression in the Treatment of Prostate CancerNew England Journal of Medicine, 2009
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate CancerJournal of Clinical Oncology, 2008
- Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysisBMC Medical Research Methodology, 2006